The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway.
about
Advances in targeting signal transduction pathwaysSodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.Gerosuppression in confluent cells.Quantitative analysis of male germline stem cell differentiation reveals a role for the p53-mTORC1 pathway in spermatogonial maintenance.A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal.MTOR-driven quasi-programmed aging as a disposable soma theory: blind watchmaker vs. intelligent designer.Dysregulation of the mTOR pathway in p53-deficient mice.cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.The maintenance of epigenetic states by p53: the guardian of the epigenome.LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.Immunosuppressants in cancer prevention and therapyNeurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
P2860
Q27686983-105D0C08-E5D4-4056-B4B5-8C921522D400Q34100963-41F3659B-4E87-4B67-BB3C-191ACFE9E20FQ34391710-B5338B1E-0D7B-42D4-A4A3-0A1C2AFC83D1Q34786457-474E7831-332E-4440-A0B4-B73D7DB7E0C0Q34982499-57E58EFF-EA25-4D83-AE23-116D42B6D9B7Q36780816-32E9F7D2-3A8B-4CAE-A9CE-F29ED19CF3A2Q37029389-245DA5F9-ECA8-4819-BF53-0CDB19F29959Q37075896-15060953-6781-4278-93E7-19358705C20FQ37548879-871B7ECE-9842-4ACC-9096-5657619A9F84Q41878064-36B8F495-BD6E-4A0A-A839-6EF5FD8210B3Q42153515-3107A236-A7A1-4AF6-957A-989399C972A8Q42503075-E5A66644-189C-4D4D-900D-3C530AB9E057Q42505783-1F0743E6-AC53-472B-BA3F-8A3EA5271811Q58737028-6A62F231-20F4-4F24-AAF5-3AEE30171734
P2860
The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The interfaces between signal ...... the Parkinson Disease pathway.
@en
type
label
The interfaces between signal ...... the Parkinson Disease pathway.
@en
prefLabel
The interfaces between signal ...... the Parkinson Disease pathway.
@en
P2093
P2860
P356
P1433
P1476
The interfaces between signal ...... the Parkinson Disease pathway.
@en
P2093
Anna M Puzio-Kuter
Arnold J Levine
Chris R Harris
P2860
P304
P356
10.18632/ONCOTARGET.759
P407
P577
2012-11-01T00:00:00Z